Definitive Healthcare (DH)
(Real Time Quote from BATS)
$4.42 USD
+0.01 (0.23%)
Updated Sep 30, 2024 12:54 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Definitive Healthcare Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 251 | 223 | 166 | 118 | 86 |
Cost Of Goods | 47 | 43 | 41 | 30 | 19 |
Gross Profit | 204 | 180 | 125 | 88 | 67 |
Selling & Adminstrative & Depr. & Amort Expenses | 534 | 221 | 150 | 102 | 85 |
Income After Depreciation & Amortization | -330 | -41 | -25 | -14 | -18 |
Non-Operating Income | 37 | 10 | -10 | 0 | 0 |
Interest Expense | 15 | 8 | 26 | 36 | 18 |
Pretax Income | -308 | -39 | -61 | -51 | -36 |
Income Taxes | -19 | -17 | 1 | 0 | 0 |
Minority Interest | -87 | 0 | -10 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -290 | -22 | -61 | -51 | -36 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -202 | -22 | -51 | -51 | -36 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 23 | 25 | 41 | 49 | 18 |
Depreciation & Amortization (Cash Flow) | 353 | 66 | 66 | 63 | 36 |
Income After Depreciation & Amortization | -330 | -41 | -25 | -14 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 112.77 | 101.11 | 91.92 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.01 | 0.04 | 0.09 | NA | NA |
Diluted Net EPS (GAAP) | -1.79 | -0.06 | -0.19 | -0.40 | NA |
Fiscal Year end for Definitive Healthcare Corp falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 63.74 | 63.48 | 65.93 | 65.33 | 60.96 |
Cost Of Goods | 13.28 | 13.10 | 12.51 | 11.90 | 11.17 |
Gross Profit | 50.45 | 50.38 | 53.42 | 53.43 | 49.79 |
SG&A, R&D, and Dept/Amort Expenses | 420.09 | 66.63 | 63.93 | 348.81 | 61.86 |
Income After SG&A, R&D, and Dept/Amort Expenses | -369.64 | -16.25 | -10.51 | -295.38 | -12.07 |
Non-Operating Income | 45.32 | 6.57 | 1.86 | 33.05 | 2.78 |
Interest Expense | 3.76 | 3.82 | 3.90 | 3.90 | 3.79 |
Pretax Income | -328.09 | -13.50 | -12.56 | -266.22 | -13.09 |
Income Taxes | -21.90 | -0.78 | 1.18 | -17.53 | -1.48 |
Minority Interest | -92.55 | -3.20 | -3.25 | -77.16 | -3.04 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -306.19 | -12.72 | -13.73 | -248.69 | -11.61 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -213.64 | -9.52 | -10.48 | -171.53 | -8.57 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 117.75 | 117.43 | 116.42 | 114.53 | 111.77 |
Diluted EPS Before Non-Recurring Items | 0.03 | -0.02 | -0.01 | 0.01 | 0.00 |
Diluted Net EPS (GAAP) | -1.81 | -0.08 | -0.10 | -1.50 | -0.08 |